AMANDA HILDEBRAND: Open Payments
NPI 1922623156 · SPRINGFIELD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$79 in 4 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $1,372 · 2025 $79
Food & beverage: $79
| Company | Payments | Amount |
|---|---|---|
| ARS Pharmaceuticals Operations, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
| GENZYME CORPORATION | 1 | $15 |
Products named: NEFFY, HYQVIA, INGREZZA, DUPIXENT.
Industry payments across IL — which companies pay providers there.
